Program

Thank you for your interest in the AMP 2018 Annual Meeting & Expo!

The AMP 2018 Program Committee has been working hard to plan a comprehensive program. We hope to connect you to the theme of "Precision Medicine Starts Here" by incorporating topics below into the Program in order to encourage dialogue and foster discussion amongst all attendees.

Topics:

  • Liquid Biopsies in Clinical Practice
  • Factors that Affect Immunotherapies
  • Emerging Technologies in Diagnostics: CRISPR, AI/Deep Learning Software, Single Cell DNA and RNA Sequencing, and More
  • Novel Biomarkers and Its Role in Disease and Therapy
  • Microbiome and Human Health
  • Next-generation Sequencing: Dealing with Challenging Regions, Clinical Advances, and Educational Sessions
  • Dealing with Big Data
  • Molecular Diagnostics Case Studies

 

Meeting Paths:

AMP Meeting Paths are a convenient way to tailor your meeting experience around the content you most want to see.The 2018 Program Committee has carefully examined the scientific program and identified seven paths that will direct you to sessions based on your favored area of interest. Select the link below to get started or scroll down to view the full program.

 

Session Recordings:

Many of the AMP 2018 Meetings & Expo sessions will be recorded and made available for purchase individually or
as a bundle on AMPEDTM Online.

 

Visit the Program Grid to see which sessions will be recorded.

 

Tuesday, October 30, 2018

GENERAL INFORMATION

8:00am - 5:30pm

AMP Reference Materials Forum (Register here for free)

10:30am - 11:15am

Executive Committee Meetings (Invitation Only)

11:30am - 6:00pm

Board of Directors Meeting (Invitation Only)

2:00pm - 6:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

6:30pm

Board of Directors Dinner (Invitation Only)

 

Wednesday, October 31, 2018

GENERAL INFORMATION

7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:30am - 5:00pm

AMP Committee Meetings (Invitation Only)

8:00am - 5:00pm

Corporate Workshop Day (No Registration Required!)

8:30am - 3:45pm

Molecular Pathology Outreach Course (MPOC)

(Separate Registration)

4:45pm - 5:45pm

Volunteer Appreciation Reception (Invitation Only)

6:00pm - 7:00pm

MGP Program Directors Meeting (Invitation Only)

7:00pm - 8:00pm

Trainee Networking Hour (Offsite)

 

Thursday, November 1, 2018

GENERAL INFORMATION

6:30am - 8:00am

Poster Set-Up

6:45am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

11:30am - 4:30pm

Exhibit Hall Open

5:45pm - 7:00pm

Welcome Reception (In the Exhibit Hall)

(Supported by QIAGEN)

AMP Central Activities (Schedule)

7:00am - 8:00am

Continental Breakfast

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Genomics of Pediatric AML and MDS

Jeffery Klco, MD, PhD, St Jude Children's Research Hospital, Memphis, TN, USA

Finding the "Indel" in the Haystack

Large Indel Detection in Clinical NGS Assays
Sabah Kadri, PhD, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

Personalized Genomics: Advancing Continuity in Research to Clinical Care

Vincent Magrini, PhD, Institute for Genomic Medicine (IGM) at Nationwide Children's Hospital, Columbus, OH, USA
Catherine E. Cottrell PhD PhD, Nationwide Children's Hospital, Columbus, OH, USA

Lab of the Future: Cool Toys for the Diagnosis of Infectious Diseases

Validation of the Karius Microbial Cell-free DNA Sequencing Test for Infectious Disease
Timothy A. Blauwkamp, PhD, Karius, Inc., Redwood City, CA, USA

A Smart Diagnostic: Technology that Learned to Identify and Count Individual Bacteria in Blood
Stephanie I. Fraley, PhD, University of California, San Diego, CA, USA

Case Studies in Genetics & Informatics

Occurrence of Medulloblastoma in a Patient with Curry-Jones Syndrome

Binu Porath, PhD, Children's Mercy Hospital, Kansas City, MO, USA

Identification of a Novel Likely Pathogenic PIK3R1 Variant by Targeted Next-Generation Sequencing Analysis in a Patient with Overgrowth Syndrome and Lymphatic Malformation
Christopher Suciu, MD, MS Washington University School of Medicine in St. Louis, St. Louis, MO, USA

Sex Check: Verifying Patient Sex Based on Off-Panel SNPs on the X Chromosome
Jennifer Bynum, MD, Johns Hopkins, Baltimore, MD, USA

A Discrepancy Between the Human Reference Genome (GRCh37) and Transcriptome (RefSeq) Results in the Incorrect Annotation of a Clinically-Relevant Sequence Variant in RECQL4
Lisa Lansdon, PhD, Children's Mercy Kansas City, Kansas City, MO, USA

8:00am - 8:15am

Break

8:15am - 8:30am

Opening Remarks

Lynne V. Abruzzo MD, PhD
Ohio State University Medical Center, Columbus, OH, USA and 2018 Program Chair

8:30am - 9:45am

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

Reimagining Healthcare: Next Generation DNA Sequencing to Ultrasound-on-a-Chip

Jonathan Rothberg, PhD, Founder, Chairman, and CEO of Butterfly Network, Inc. CT, USA

9:45am -10:15am

Coffee Break

(Supported by Philips)

10:15am - 11:45am

PLENARY SESSION

Life Starts with DNA: Sequencing of the Baby Genome

Newborn Genomic Sequencing for Diagnosis and Screening
Jonathan S. Berg, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

The Babyseq Project: A Study of Newborn Genomic Sequencing
Ingrid A. Holm, MD, MPH, Boston Children's Hospital/Harvard Medical School, Boston, MA, USA

11:45am - 1:00pm

General Lunch - Visit Exhibit Hall and View Posters

Networking Lunches (Schedule)

AMP Central Activities (Schedule)

Innovation Spotlight Stage (Schedule)

1:00pm - 2:30pm

CONCURRENT WORKSHOPS

Variant Interpretation: Challenges and Progress towards Solutions

Challenges of Variant Interpretation: Sources of Variability among VITAL Participants
Elaine Lyon, PhD, Hudson Alpha, Huntsville, AL, USA

ClinVar and ACMG Variant Classification Standards for Inherited Cardiovascular Disease

Birgit Funke, PhD, Veritas Genetics, Danvers, MA, USA
Harvard Medical School, Boston, MA, USA

Role of Next Generation Sequencing for Outbreak Investigation

Viral Genomics in the Clinical Lab
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA

NGS for Natural Disasters
Randall Olsen, MD, PhD, Houston Methodist Hospital and Research Institute, Houston, TX, USA

Cutting Edge Informatics Infrastructure for Personalized Medicine

Leveraging Computer Infrastructure to Scale Clinical Bioinformatics
Elaine Gee, PhD, BigHead Analytics Group, Windsor, CA, USA

Standards and Apps for Genomic Decision Support
Jeremy L. Warner, MD, MS, Vanderbilt University, Nashville, TN, USA

Payer Perspectives on Coverage and Reimbursement of Molecular Diagnostics
(Sponsored by the AMP Economic Affairs Committee)

Laurence J. Clark, MD, National Government Services, E. Syracuse, NY, USA

Paul B. Gerrard, MD, Palmetto GBA, Columbia, SC, USA

Charles Matthews, ClearView Health Partners, Newton, MA, USA

Gabriel Bien-Willner, MD, Palmetto GBA, Columbia, SC, USA

Michael Fine, MD, Health  Net, Laguna Beach, CA, USA

Molecular Tumor Board

Elizabeth Swisher, MD, University of Washington, Seattle, WA, USA

Stephen Lincoln, Invitae, San Francisco, CA, USA

Eric H. Bernicker, MD, Houston Methodist Hospital, Houston, TX, USA

Valentina Nardi, Massachusetts General Hospital, Boston, MA, USA

Jonathan A. Nowak, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA

Angela Jacobson, MS, University of Washington, Seattle, WA, USA

2:30pm - 4:15pm

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

Innovation Spotlight Stage (Schedule)

4:15pm - 5:45pm

PLENARY SESSION

Somatic and Germline Mutations in Hematologic Malignancies

Spliceosome Gene Mutations in MDS
Matthew Walter, MD, Washington University, St. Louis, MO, USA

Inherited Hematopoietic Malignancies
Lucy A. Godley, MD, PhD, The University of Chicago, Chicago, IL, USA

SPECIAL SESSION: INFECTIOUS DISEASES

Meningitis/Encephalitis Syndromic Testing in the Clinical Setting: Is it Ready for Prime Time?

Are Meningitis/Encephalitis Panels Ready for Prime Time?
Kevin Alby, PhD, University of Pennsylvania, Philadelphia, PA, USA

Point-Counterpoint: Molecular Diagnosis of Meningitis/Encephalitis
Jennifer Dien Bard, PhD
Children's Hospital Los Angeles, Los Angeles, CA, USA
University of Southern California, Los Angeles, CA, USA

5:45pm - 7:00pm

Welcome Reception (In the Exhibit Hall)

(Supported by QIAGEN)

AMP Central Activities (Schedule)

7:00pm - 9:00pm

Canadian Members Dinner

7:30pm - 8:30pm

Special Event: Emerging Targets for  the Diagnosis of Cancer: NTRK Fusion in Solid Tumors
Developed through a strategic collaboration between AMP and Medscape Education Oncology

 

Friday, November 2, 2018

GENERAL INFORMATION

6:45am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

9:00am - 4:00pm

Exhibit Hall Open

7:00am - 8:00am

Continental Breakfast

(Supported by EntroGen)

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Keys to Publishing in Scientific Journals

Barbara A. Zehnbauer, PhD, Emory University School of Medicine, Atlanta, GA, USA

Conceptual Nuts and Bolts of Visualizing Big Data in Genomics

Visualizations for Genomic Data, the GTEx Experience
Jared L. Nedzel, Broad Institute, Cambridge, MA, USA
Katherine Huang, Broad Institute, Cambridge, MA, USA

The Growth and Evolution of Consumer Genetic Testing
(Sponsored by the Professional Relations Committee)

Jill Hagenkord, MD, Color Genomics, Burlingame, CA, USA

Elissa Levin, MS, Helix, San Francisco, CA, USA

Danielle Bonadies, MS, My Gene Counsel, Branford, CT, USA

Altovise Ewing, PhD, 23and Me , Mountain View, CA, USA

AMP Guidance/Standards for NGS Germline Variant Confirmation

Kristy Crooks, PhD, University of Colorado, Denver, CO, USA

Case Studies in Solid Tumor

Circulating Tumor DNA (ctDNA) Detection in CSF in a Patient with Metastatic Melanoma to the CNS
Andres Moon, MD, University of Washington, Seattle, WA, USA

An Unusual Driver Mutation in a Lung Adenocarcinoma
Erik Nohr, MD, Stanford Healthcare, Palo Alto, CA, USA

LMNA/NTRK1 Fusion in a Paravertebral Soft Tissue Mass
Yulei Shen, MD, PhD, Baylor College of Medicine, Houston, TX, USA

Recurrent Glioblastoma with Primary and Secondary Features in a Patient with a Deficiency of Mismatch Repair
Martin Powers, MD, University of California San Diego, San Diego, CA, USA

8:00am - 8:15am

 

Break

8:15am - 9:15am

SPECIAL SESSION: INFECTIOUS DISEASES

The Role of Genomic Susceptibility Testing in Predicting Antimicrobial Responses

Use of Molecular Testing to Predict Gonorrhea Treatment
Jeffrey D. Klausner, MD, MPH, University of California, Los Angeles, CA, USA

Value of Molecular AST Methods for Bacteria: Are We There?
Romney M. Humphries, PhD, Accelerate Diagnostics, Tucson, AZ, USA

8:15am - 9:45am

PLENARY SESSION

Tumoral Genomic Diversity

Predictor of Response to PARP Inhibitors
Elizabeth M. Swisher, MD, University of Washington, Seattle, WA, USA

Leveraging Personalized Medicine for Diagnosis and Treatment of Pancreatic Cancer
Brian Wolpin, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, USA

9:45am - 10:45am

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

Innovation Spotlight Stage (Schedule)

10:45am - 11:45am

CONCURRENT WORKSHOPS:

Platform Presentations of Selected Abstracts

Abstracts are selected by the Program Committee

Platform Presentations of Selected Genetics Abstracts

G044 - Designing and Implementing NGS Tests for Inherited Disorders – a Practical Framework with Step-by-Step Guidance for Clinical Laboratories
Avni B. Santani, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA

G025 - Verification of Very Small Copy Number Variants (Micro CNVs) Detected on Whole Genome CMA Analysis and Implications for Clinical Reporting
Ulrike P. Kappes, MPH, MD, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

G026 - Two-site Evaluation of a One-tube PCR/CE Assay that Resolves CAG Length Polymorphisms in Exon 1 of the HTT Gene
Sarah Statt, PhD, Asuragen, Austin, TX, USA

G021 - Brazilian Panorama of Whole Exome: Details of 315 Cases
Roberta Sitnik, PhD, Hospital Israelita Albert Einstein, São Paulo, Brazil

Platform Presentations of Selected Hematopathology Abstracts

H025 - Ultradeep Error Corrected Next-generation Sequencing (NGS) of ABL1 Kinase Domain Mutations in BCR-ABL1 Positive Malignancies
Nikhil Patkar, MD, Tata Memorial Center, Mumbai, Maharashtra, India

H041 -  Longitudinal Monitoring of AML Tumors with High-throughput Single-Cell DNA Sequencing Reveals Rare Clones Prognostic for Disease Progression and Therapy Response
Dennis J. Eastburn, PhD, Mission Bio, Inc., South San Francisco, CA, USA

H014 - Mate Pair Sequencing: Ushering Cytogenetics Into the Era of Personalized Medicine
Nicole Hoppman, PhD, Mayo Clinic, Rochester, MN, USA

H039 - Donor-derived Clonal Hematopoiesis of Indeterminant Potential Mutations are Detected in Transplant Recipients after Allogeneic Hematopoietic Stem Cell Transplant
Jennifer Dunlap, MD, Oregon Health & Science University, Portland, OR, USA

Platform Presentations of Selected Infectious Diseases Abstracts

ID004 - Evaluation of a Novel Isothermal Amplification Assay for Detection and Genotyping of Human Papillomavirus in Formalin-fixed Paraffin-embedded Tissue of Oropharyngeal Carcinomas
Yi-Wei Tang, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID012 - Comprehensive Solid Tumor Microbiome Profiling via Analysis of Unmapped Reads in Large Panel, Hybridization Capture-based NGS Assay Data
Chad M. Vanderbilt, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID063 - A Quantitative, Multiplexed RNA Detection Platform for Rapid Pathogen Identification and Phenotypic Antibiotic Susceptibility Testing (AST) using NanoString(™) Technology
Roby P. Bhattacharyya, MD, PhD, Broad Institute, Cambridge, MA, USA
Massachusetts General Hospital, Boston, MA, USA

ID007 - The Diagnostic Yield of Universal Pathogen Detection by Next-Generation Sequencing Compared to the Standard of Care in Patients with Pneumonia
Brittany A. Young, MD, PhD, University of Utah, Salt Lake City, UT, USA

Platform Presentations of Selected Informatics Abstracts

I025 - Identification of Viral Integration Sites in Cancer Genomes using Unmapped Reads in Targeted Next-Generation Sequencing Data
Anita S. Bowman, MS, Memorial Sloan Kettering Cancer Center, New York, NY, USA

I027 - Detection of Microsatellite Instability Using a Large Next-generation Sequencing Panel Across Diverse Tumor Types
Susan J. Hsiao, MD, PhD, Columbia University Medical Center, New York, NY, USA

I009 - Personalized Transcriptomic Drug Profiling in Non-small Cell Lung Cancer
Zachary Abrams, PhD, The Ohio State University, Athens, OH, USA

I034 - Assessing Cancer Diagnosis From Clinical Genomics Data Using Machine Learning
Paul R. Hess, MD, PHD, University of Pennsylvania, Philadelphia, PA, USA

Platform Presentations of Selected Solid Tumors Abstracts

ST002 - Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer
Jonathan Dudley, MD, Stanford University, Stanford, CA, USA

ST055 - DNA Sequencing of Human, Epstein-Barr Virus, and Helicobacter Pylori Genomes to Classify and Monitor Gastric Adenocarcinoma
Margaret L. Gulley, MD, University of North Carolina, Chapel Hill, NC, USA

ST107 - Clinical Validation of MSK-ACCESS: An Ultrasensitive Next-generation Sequencing Assay for Liquid Biopsies in the Clinic
A. Rose Brannon, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ST144 - Prognosis Determined by Tumor Mutational Burden (TMB) Using Whole Exome Sequencing (WES)
Evan Fernandez, MS, Weill Cornell Medicine, New York, NY, USA

11:45am - 1:00pm

General Lunch - Visit Exhibit Hall and View Posters

Networking Lounge

Networking Lunches (Schedule)

AMP Central Activities (Schedule)

Innovation Spotlight Stage (Schedule)

12:15pm - 1:00pm

SPECIAL SESSION: INFECTIOUS DISEASES

ID Town Hall Meeting

1:00pm - 2:30pm

PLENARY SESSION

Microbiome and Predictive Response to Immunotherapy

Microbiome Changes with Infectious Complications During Stem Cell Transplantation
Ying Taur, MD, MPH, Memorial Sloan Kettering Cancer Center, New York, NY, USA

The Intestinal Virome: From Chronic Inflammation to Bacteriophage Therapy Targeting Multidrug Resistant Bacteria
Breck A. Duerkop, PhD, University of Colorado School of Medicine, Aurora, CO, USA

2:30pm - 3:30pm

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

(Even-numbered posters Attended)

Innovation Spotlight Stage (Schedule)

3:30pm - 5:00pm

CONCURRENT SYMPOSIA

Utilization of CRISPR/Cas Technique as Anti-Viral Therapeutic Agent and as an Adaptive Immune Modulator in DNA Editing and RNA Targeting

CRISPR/Cas9 Targeting and Inactivation of Viral DNA Genomes
Bryan R. Cullen, PhD, Duke University Medical Center, Durham, NC, USA

Programmable RNA-targeting CRISPR-Cas Enzymes for RNA Detection and Therapeutics
Mitchell R. O'Connell, PhD, University of Rochester, Rochester, NY, USA

Clinical Advances in NGS

Robert L. Nussbaum, MD, Invitae Corporation, San Francisco, CA, USA

Wayne W. Grody, MD, PhD, University of California, Los Angeles, CA, USA

In Silico Sequencing Data and Tools: Current and Future Applications in Clinical Practice

"In Silico" Proficiency Testing
John D. Pfeifer, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

In Silico Proficiency Testing for Clinical Next Generation Sequencing
Karl V. Voelkerding, MD, University of Utah School of Medicine, Salt Lake City, UT, USA

5:00pm - 5:15pm

Break

5:15pm - 6:30pm

Business Meeting and Awards Session

(Open to All Registered Attendees)

7:00pm - 10:30pm

AMP 2018 Social Event (Separate Registration)

 

 

Saturday, November 3, 2018

GENERAL INFORMATION

6:45am - 2:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

9:00am - 1:30pm

Exhibit Hall Open

12:30pm - 1:30pm

Poster Removal

7:00am - 8:00am

Continental Breakfast

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

AMP Guidance for Non-standard or Emerging NGS Applications: Liquid Biopsy

Christina Lockwood, PhD, University of Washington, Seattle, WA, USA

Christopher D. Gocke, MD, Johns Hopkins University, Baltimore, MD, USA

Prior's Puzzlers

Thomas W. Prior, PhD, Case Western Reserve University, Cleveland, OH, USA

Strength in Numbers: Building an Academic Consortium to Facilitate Cost-Effective Clinical NGS

Jeremy Segal, MD, PhD, University of Chicago, Chicago, IL, USA

Dara Aisner, MD, PhD, University of Colorado, Denver, CO, USA

Case Studies in Hematopathology

Identification of a Rare Germline POT1 Mutation by Targeted Next-Generation Sequencing of a Splenic Marginal Zone Lymphoma
Audrey Jajosky, MD, PhD, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Identification of Acute Leukemia Risk Mutations in a Child with Severe Congenital Neutropenia
Jennifer Yoest, MD, Washington University School of Medicine in St. Louis, St. Louis, MO, USA              

Whole Genome Sequencing Identifies Cryptic High-Risk Cytogenetic Findings In A Patient With Acute Myeloid Leukemia
Michael Alberti, MD, PhD, Washington University School of Medicine in St. Louis, St. Louis, MO, USA

A Case of Myeloid Neoplasm with Germline Predisposition: Connecting the Clinical, Laboratory, Morphology and Molecular Dots
Fatima Zahra Jelloul, MD, MD Anderson Cancer Center, Houston, TX, USA

Platform Presentation of Selected Technical Topics Abstracts

TT074 - Multi-Patient Longitudinal Monitoring of Cancer Mutations from Circulating DNA of Using Personalized Single Color Digital PCR Assays
Christina M. Bouwens, Stanford University, Stanford, CA, USA

TT059 - Cell-free DNA Allograft Rejection Monitoring Using Low-coverage Whole Genome Sequencing
Niklas Krumm, MD, PhD, University of Washington, Seattle, WA, USA

TT070 - Universal Design and Rapid PCR for Genotyping by High Resolution Melting
Jessica Houskeeper, MRes , University of Utah, Salt Lake City, UT, USA

TT046 - The NIH Genetic Testing Registry (GTR): Test Methodologies as a Sensor of the Precision Medicine Environment
Adriana Malheiro, MS, National Center for Biotechnology Information, NIH, Bethesda, MD, USA

 

8:00am - 8:15am

 

Break

 

8:15am - 9:15am

SPECIAL SESSION: INFECTIOUS DISEASES & MOLECULAR ONCOLOGY

Test Utilization and Clinical Utility of Molecular Test

Opportunities and Challenges in Laboratory Stewardship: Leaders Apply Here
Gary Procop, MD, Cleveland Clinic, Cleveland, OH, USA

8:15am - 9:45am

PLENARY SESSION

Artificial Intelligence in Genomic Medicine

Artificial Intelligence in Cancer Genomics and Therapy
Olivier Elemento, PhD, Weill Cornell Medicine - Englander Institute for Precision Medicine, New York, NY, USA

Probabilistic Graphical Models for Integrative Analysis of Pathomics Data
Panagiotis Benos, PhD, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

9:45am - 10:45am

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

(Odd-numbered posters Attended)

Innovation Spotlight Stage (Schedule)

10:45am - 12:15pm

WORKSHOPS

Clinical Implementation of Liquid Biopsy for Cancer Patients

Clinical Applications of Digital PCR
Maria Arcila, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Liquid Biopsy for Solid Tumors: Promises and Perils

Mark Routbort, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Show Me the Data: Visualization At the Interface of Molecular Pathology and Patient Care

Cancer Genomics Visualization across Scales: Nucleotides to Cohorts
Nils Gehlenborg, PhD, Harvard Medical School, Boston, MA, USA

Data Commons for Precision Cancer Medicine
Ethan Cerami, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

Enterovirus D68 and Acute Flaccid Myelitis: What We've Learned Since 2014

The Role of Enterovirus D68 in Acute Flaccid Myelitis
Kevin Messacar, MD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

Epidemiology, Surveillance, and Diagnosis of Enterovirus D68
Samuel Dominguez, MD, PhD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

Training the Next Generations of Next Gen

Innovations and Transitions in ABMGG's Continuing Certification Program
Cecily P. Marroquin, American Board of Medical Genetics & Genomics, Rockville, MD, USA

Fellowship Training and Continuing Certification in Molecular Pathology
Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL, USA


Sarah P. Farrell, PhD

Best Practices for Clinical Validation of NGS Bioinformatics Pipeline

AMP Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines
Somak Roy, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA

12:15pm - 1:30pm

Exhibitor Appreciation Lunch - Visit Exhibit Hall, and View Posters

AMP Central Activities (Schedule)

Networking Lounge

1:30pm - 3:00pm

CONCURRENT SYMPOSIA

Finding the Patient Perspective: Molecular Testing in Advanced NSCLC

(Developed through a partnership between Medscape and the Association for Molecular Pathology)
 

Eric H. Bernicker MD, Houston Methodist Hospital, Houston, TX, USA

Christina Lockwood, PhD, University of Washington, Seattle, WA, USA

Lynette M. Sholl, MD, Brigham & Women's Hospital, Boston, MA, USA USA

Don Stranathan, Lung Cancer Survivor/Advocate, Santa Rosa, CA, USA

Precision Medicine in Mature Lymphoid Malignancies

Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia
Jennifer A. Woyach, MD, The Ohio State University, Columbus, OH, USA

Towards a Genomic Classification of T Cell Malignancies: Opportunities for Precision Medicine
Megan S. Lim, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA

Metagenomic Characterization of Molecular Scientists

Christopher E. Mason, PhD, Weill Cornell Medicine, New York, NY, USA

3:00pm - 3:15pm

Break

3:15pm - 4:45pm

PLENARY SESSION

Hypermutation and Mutation Signature Detection in Cancer

Clinical Implications of Mutational Load and Signatures on Replication Repair Deficiency in Cancer
Uri Tabori, MD, PhD, Hospital for Sick Children, Toronto, Ontario, Canada

Hypermutation in Cancer: Burden and Signatures of Mutational Processes
Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

4:45pm - 5:00pm

Closing Remarks

Lynne V. Abruzzo MD, PhD
Ohio State University Medical Center, Columbus, OH, USA and 2018 Program Chair

Neal I. Lindeman, MD, Brigham & Women's Hospital, Boston, MA, USA and 2019 Program Chair